Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109
Clinical trial NCT01780077 · COMPLETED
Trial details
- NCT number
- NCT01780077
- Sponsor
- RXi Pharmaceuticals, Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.